Biogen (NASDAQ:BIIB) PT Set at $213.00 by Royal Bank Of Canada
Biogen (NASDAQ:BIIB – Get Free Report) has been assigned a $213.00 target price by equities researchers at Royal Bank Of Canada in a research note issued to investors on Wednesday, MarketBeat.com reports. The firm currently has an “outperform” rating on the biotechnology company’s stock. Royal Bank Of Canada’s target price would indicate a potential upside […]
Biogen (NASDAQ:BIIB – Get Free Report) has been assigned a $213.00 target price by equities researchers at Royal Bank Of Canada in a research note issued to investors on Wednesday, MarketBeat.com reports. The firm currently has an “outperform” rating on the biotechnology company’s stock. Royal Bank Of Canada’s target price would indicate a potential upside […]
